首页> 外文OA文献 >Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial

【2h】

Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial

机译：经皮冠状动脉介入治疗后口服维拉帕米对临床结局和血管造影再狭窄的作用评估随机，双盲，安慰剂对照，多中心维拉帕米缓释用于预防血管成形术（VESPA）后的心血管事件

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Bestehorn Hans-Peter; Neumann Franz-Josef; Büttner Heinz Joachim; Betz Peter; Stürzenhofecker Peter; von Hodenberg Eberhard; Verdun Antoine; Levai Laszlo; Monassier Jean Pierre; Roskamm Helmut;
展开▼
作者单位

展开▼
年度 2004
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Starc II, a multicenter randomized placebo-controlled double-blind clinical trial of trapidil for 1-year clinical events and angiographic restenosis reduction after coronary angioplasty and stenting. [J] . Maresta A, Balducelli M, Latini R, Catheterization and cardiovascular interventions: Official journal of the Society for Cardiac Angiography & Interventions . 2005,第3期

机译：Starc II，一种多中心随机安慰剂控制的Trapidil的双盲临床试验为1年的临床事件和冠状动脉血管成形术后降低血管造影再狭窄降低。
2. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. [J] . Ribichini F, Tomai F, De Luca G, Journal of cardiovascular medicine . 2009,第2期

机译：一项多中心随机研究，旨在测试口服泼尼松对免疫抑制疗法的预防作用，以预防经皮冠状动脉介入治疗后的再狭窄：可的松加BMS或DES与单独使用BMS消除再狭窄（CEREA-DES）-研究设计和原理。
3. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale. [J] . Ribichini F, Tomai F, De Luca G, Journal of cardiovascular medicine . 2009,第2期

机译：一项多中心随机研究，旨在测试口服泼尼松对免疫抑制疗法的预防作用，以预防经皮冠状动脉介入治疗后的再狭窄：可的松加BMS或DES与单独使用BMS消除再狭窄（CEREA-DES）-研究设计和原理。
4. Intracoronary Laser Photoremodeling (LP). The New Method in Restenosis Prevention After Percutaneous Coronary Intervention (PCI) [C] . A. Derkacz, D. Bialy, M. Protasiewicz, International Congress on Coronary Artery Disease . 2003

机译：Intracoronary激光光敏eModeling（LP）。经皮冠状动脉干预后再狭窄预防的新方法（PCI）
5. A randomized, double-blind, placebo-controlled, clinical trial of curcuminoids in oral lichen planus. [D] . Wu, Nita Chainani. 2005

机译：口服扁平苔藓中姜黄素类药物的随机，双盲，安慰剂对照临床试验。
6. Study protocol of Prednisone in episodic Cluster Headache (PredCH): a randomized double-blind placebo-controlled parallel group trial to evaluate the efficacy and safety of oral prednisone as an add-on therapy in the prophylactic treatment of episodic cluster headache with verapamil [O] . Dagny Holle, Jan Burmeister, André Scherag, 2013

机译：泼尼松在发作性丛集性头痛（PredCH）中的研究方案：一项随机双盲安慰剂对照的平行组试验评估口服泼尼松作为预防性治疗维拉帕米发作性丛集性头痛的附加疗法的有效性和安全性
7. Evaluation of ketanserin in the prevention of restenosis after percutaneous transluminal coronary angioplasty. A multicenter randomized double-blind placebo-controlled trial. [O] . P W Serruys, W Klein, J P Tijssen, 1993

机译：经皮透视冠状动脉血管成形术后预防再狭窄的酮蛋白评价。多中心随机双盲安慰剂对照试验。

Evaluation of the effect of oral verapamil on clinical outcome and angiographic restenosis after percutaneous coronary intervention The randomized, double-blind, placebo-controlled, multicenter verapamil slow-release for prevention of cardiovascular events after angioplasty (VESPA) trial

著录项

相似文献

相关主题

期刊订阅